Issue 11/2000
Content (19 Articles)
Safety of high-dose nicotinamide: a review
M. Knip, I. F. Douek, W. P. T. Moore, H. A. Gillmor, A. E. M. McLean, P. J. Bingley, E. A. M. Gale
Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency
C. Marçais, S. Bernard, M. Merlin, M. Ulhmann, B. Mestre, L. Rochet-Mingret, A. Revol, F. Berthezene, P. Moulin
Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
S. S. Soedamah-Muthu, H. M. Colhoun, M.-R. Taskinen, B. Idzior-Walus, J. H. Fuller
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
R. E. Gilbert, D. J. Kelly, A. J. Cox, J. L. Wilkinson-Berka, J. R. Rumble, T. Osicka, S. Panagiotopoulos, V. Lee, E. C. Hendrich, G. Jerums, M. E. Cooper
Stimulatory effect of increased non-esterified fatty acid concentrations on proinsulin processing in healthy humans
N. Stefan, A. Fritsche, A. Madaus, H. Häring, M. Stumvoll
Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins
M. Collison, I. W. Campbell, I. P. Salt, A. F. Dominiczak, J. M. C. Connell, H. Lyall, G. W. Gould
Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes
H. Steinbrenner, T. Lohmann, B. Ostendorf, W. A. Scherbaum, J. Seissler
Antibodies against advanced glycation end product Nɛ-(carboxymethyl)lysine in healthy controls and diabetic patients
D. Vay, M. Vidali, G. Allochis, C. Cusaro, R. Rolla, E. Mottaran, G. Bellomo, E. Albano
TNFα and IFNγ potentiate IL-1β induced mitogen activated protein kinase activity in rat pancreatic islets of Langerhans
N. Aa. Andersen, C. M. Larsen, T. Mandrup-Poulsen
Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome
K. G. Rowley, D. M. Iser, J. D. Best, K. O'Dea, D. Leonard, R. McDermott
Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation
J. Spranger, H.-P. Hammes, K. T. Preissner, H. Schatz, A. F. H. Pfeiffer
The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in Type II diabetic subjects
P. Schrauwen, G. Schaart, W. H. M. Saris, L. J. Slieker, J. F. C. Glatz, H. Vidal, E. E. Blaak
Retina accumulates more glucose than does the embryologically similar cerebral cortex in diabetic rats
J. Tang, X. W. Zhu, W. D. Lust, T. S. Kern
An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort
A. Meirhaeghe, P. Amouyel, N. Helbecque, D. Cottel, S. Otabe, P. Froguel, F. Vasseur
Genomic structure of mouse IA-2: comparison with its human homologue
K. Saeki, J. Xie, A. L. Notkins
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus
T. Heitzer, K. Krohn, S. Albers, T. Meinertz
Defects in microvascular haemodynamics during prediabetes: contributor or epiphenomenon?
N. Wiernsperger